Insulet Corp (PODD) financials

Insulet Corp (PODD) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Insulet Corp reported revenue of $2.71B, up 30.7% year over year, net income of $247M, diluted EPS of $3.48 and free cash flow of $350M.

Revenue (fiscal 2025)

$2.71B

Revenue growth (fiscal 2025)

30.7%

Net income (fiscal 2025)

$247M

Diluted EPS (fiscal 2025)

$3.48

Free cash flow (fiscal 2025)

$350M

Insulet Corp files with the U.S. Securities and Exchange Commission under CIK 0001145197, classified as Surgical & Medical Instruments & Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.